The MarketWatch News Department was not involved in the creation of this content. -- Heart disease affects approximately 10 percent of dogs in their lifetime1 -- VETMEDIN(R) (pimobendan) from ...
Canine mitral valve disease, most commonly stemming from myxomatous degeneration, is the predominant acquired cardiac condition in dogs. This disease is characterised by progressive deterioration of ...
CU Anschutz cardiologist John Carroll, MD, lends his expertise in mitral regurgitation and M-TEER procedures to veterinary researchers who hope to bring treatment options to man’s best friend ...
Heart disease affects approximately 10 percent of dogs in their lifetime1 VETMEDIN® (pimobendan) from Boehringer Ingelheim is the only medication approved to treat preclinical mitral valve disease in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results